Nexalin welcomes the CME Acuity team

Nexalin CEO Randall Letcavage and medical advisory board member E. Patrick Miller meet with CME Acuity principal owners David Rothman and Joel Bradus to welcome them as a new distributor of Nexalin products in the New York City metro area. The CME acuity team brings over 30 years of experience in the health care industry. They…

Read More

Comprehensive Pain Relief Group

Tustin, CA – Nexalin is proud to announce the addition of Comprehensive Pain Relief Group (CPRG) to our expanding health care provider network. In the coming weeks ahead, Nexalin treatments will be available in two new locations (Torrance and Fresno, CA). About CPRG “Comprehensive Pain Relief Group (CPRG)/GS Medical Center were formed by Gregory A….

Read More

Obama’s 2013 BRAIN Initiative

With Obama passing the BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies), the challenge is to help fund new innovative technologies that will help better understand the brain and the disorders that effect….

Cranial Electrotherapy Stimulation as a Treatment for Anxiety in Chemically Dependent Persons

Cranial electrotherapy stimulation (CES) is reported to be effective treatment for anxiety, a major presenting symptom among chemically dependent patients. In this study, 40 inpatient alcohol and/or poly-drug users were given CES or sham CES in a double blind design. An additional 20 patients served as norlmla hospital routine controls. Dependent measures of anxitety were the Profile of Mood States, the Institute for Personality and Ability Testing Anxiety Scale, and the State/Trait Anxiety Index. CES-treated patients showed significantly greater improvement on all anxiety measures than did either control group. There were no differences in response between older and younger patients, or between the primary drug or alcohol users. No placebo effect was found on any of our measures. It is concluded that CES is a clinically significant addition to the treatment regimen for this patient population.

Ya. S. Katsnelson, V. A. Leosko: Evaluation Of The Effectiveness Of A New Method Of Transcranial Electroanalgesia For Clinical Anesthesiology

The number of people in this country exhibiting symptoms of depression and anxiety continues to grow and is projected to continue growing through the next decade at least. The symptoms of these disorders cause substantial distress for the sufferers and their families and cost society dearly each year in lost time and suboptimal job performance.

Season’s Greetings and wishing you the best in 2013!

Best wishes to you and your family this Holiday Season and throughout the coming New Year.

As we move into 2013, we recognize how important our customers and partners are to our success. Through your contributions over the past year, our Nexalin team has enjoyed the success of opening 22 new Nexalin locations. As we
continue to grow in 2013, we look to bring everyone more exciting news.

For more information about Nexalin, please visit our website at or contact the customer support center at (949) 225-4417.

Thank you all for your continued support.

Happy New Year!!
Randall Letcavage

Click here to see the full list of Nexalin practitioners.